CompletedPhase 3NCT03785964
Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SpringWorks Therapeutics, Inc.
- Principal Investigator
- Bernd Kasper, MDMannheim University Medical Center
- Intervention
- Nirogacestat oral tablet(drug)
- Enrollment
- 142 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2024
Study locations (30)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Ronald Regan UCLA Medical Center, Los Angeles, California, United States
- Stanford Cancer Center, Palo Alto, California, United States
- UCSF Mission Bay, San Francisco, California, United States
- Sarcoma Oncology Research Center, Santa Monica, California, United States
- University of Colorado Hospital-Anschutz Cancer Pavilion (ACP), Aurora, Colorado, United States
- Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, United States
- Washington Cancer Institute at MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Northwestern Memorial Hospital, Chicago, Illinois, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Massachusetts General Hosptial (MGH), Boston, Massachusetts, United States
- Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03785964 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France